Evaluation of the gene expression level of Beclin 1 and Atg10 in autophagy and in patients with acute lymphoblastic leukemia

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 510

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

IPMCMED03_010

تاریخ نمایه سازی: 6 خرداد 1398

چکیده مقاله:

Acute lymphoblastic leukemia is the most common cancer in children and juvenile, it is also seen in adults, but ratio is lower. Autophagy is a programmed catabolic process of the cell for destruction of damaged organs and this function is done with the assistance of lysozymes. Disruption of autophagy leads to abnormalities in cellular processes associated with cancer and acts like a double-edged sword. In some cancers, the expression of autophagy genes is reduced, while in some others, the expression of autophagy shows increment. In this study, we evaluated the expression of Beclin 1 and Atg10 genes in 50 patients with de novo ALL compared to 18 healthy subjects as control using relative-quantitative-RT-PCR. The majority of B-ALL patients showed a significant reduction in the Beclin1 and Atg 10 genes compared to control group (P <0.05) and also was not observed correlation between Beclin1 expression and Atg10 expression level in these patients (P =0.926) and (r =-0.013). Due to the reduced expression levels observed in the essential genes of autophagy in our ALL patients and also other studies done in this field, we supposed that deregulated autophagy can be involved in leukomogensis and also autophagy can be regarded as therapeutic target to get rid of cancer.

نویسندگان

Zahra Hasanpour

Hematology and blood Banking Department, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mehdi Allahbakhshian Farsani

HSCT Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Hossein Mohammadi

HSCT Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran